Search Login Register
Levodopa
(L Dopa)
Summary
Description:
The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.
Also Known As:
L Dopa; Larodopa; 3-Hydroxy-L-tyrosine; Dopaflex; Dopar Show All >>
Networked: 9058
relevant articles (999 outcomes,
1265 trials/studies)
for this Drug
Key Diseases for which Levodopa is
Relevant
-
Parkinson Disease (Parkinson's Disease)
:
483 outcomes 695 studies in 4869 results
-
Dyskinesias (Dyskinesia)
:
319 outcomes 356 studies in 2356 results
-
Parkinsonian Disorders (Parkinsonism)
:
93 outcomes 107 studies in 1295 results
-
Tremor (Tremors)
:
64 outcomes 26 studies in 362 results
-
Hypokinesia (Bradykinesia)
:
37 outcomes 10 studies in 182 results
Show All >>
Drugs Related to Levodopa
-
Levodopa (L Dopa)
-
Dopamine (Intropin)
-
Carbidopa (Lodosyn)
-
Dopamine Agonists (Dopamine Agonist)
-
Bromocriptine (Parlodel)
-
Dihydroxyphenylalanine (Dopa)
-
Benserazide
-
entacapone (Comtan)
-
ropinirole (Requip)
-
pramipexol (pramipexole)
Show All >>
Therapies Related to Levodopa
-
Pallidotomy
-
Deep Brain Stimulation
-
Activities of Daily Living (ADL)
-
Transplants (Transplant)
-
Drug Therapy (Chemotherapy)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.